Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- N/A
The Impact of Immunostimulating Nutrition on the Outcome of Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer
- Status
- COMPLETED
- Phase
- NA
Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib in Treating Patients With Stage IV Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer
- Status
- SUSPENDED
- Phase
- PHASE2
Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2